Banque Cantonale Vaudoise Grows Position in Mettler-Toledo International Inc. (NYSE:MTD)

Banque Cantonale Vaudoise boosted its stake in Mettler-Toledo International Inc. (NYSE:MTDGet Rating) by 78.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,360 shares of the medical instruments supplier’s stock after purchasing an additional 600 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Mettler-Toledo International were worth $1,868,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Rockbridge Investment Management LCC purchased a new stake in Mettler-Toledo International in the fourth quarter valued at approximately $25,000. Glassman Wealth Services grew its holdings in Mettler-Toledo International by 57.9% in the fourth quarter. Glassman Wealth Services now owns 30 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 11 shares during the period. Sageworth Trust Co of South Dakota purchased a new stake in Mettler-Toledo International in the fourth quarter valued at approximately $56,000. Covestor Ltd purchased a new stake in Mettler-Toledo International during the fourth quarter worth approximately $95,000. Finally, Newfound Research LLC grew its stake in Mettler-Toledo International by 83.0% during the first quarter. Newfound Research LLC now owns 86 shares of the medical instruments supplier’s stock worth $118,000 after buying an additional 39 shares during the period. 93.88% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on MTD. Wells Fargo & Company upgraded shares of Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and decreased their price objective for the stock from $1,600.00 to $1,410.00 in a research note on Monday, April 25th. UBS Group initiated coverage on shares of Mettler-Toledo International in a research note on Wednesday, July 20th. They set a “neutral” rating and a $1,237.00 price objective for the company. The Goldman Sachs Group reduced their target price on shares of Mettler-Toledo International from $1,280.00 to $1,140.00 and set a “sell” rating on the stock in a research report on Thursday, July 14th. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,369.00 to $1,406.00 and gave the stock a “neutral” rating in a research report on Monday, August 1st. Finally, TheStreet cut shares of Mettler-Toledo International from a “b” rating to a “c+” rating in a research report on Thursday, July 28th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $1,298.25.

Mettler-Toledo International Trading Up 0.1 %

MTD opened at $1,347.72 on Friday. The stock has a market capitalization of $30.34 billion, a PE ratio of 37.97, a P/E/G ratio of 3.32 and a beta of 1.12. The firm’s fifty day moving average price is $1,215.14 and its 200 day moving average price is $1,310.58. The company has a debt-to-equity ratio of 250.82, a current ratio of 1.18 and a quick ratio of 0.77. Mettler-Toledo International Inc. has a 12-month low of $1,082.78 and a 12-month high of $1,714.75.

Mettler-Toledo International (NYSE:MTDGet Rating) last posted its quarterly earnings results on Friday, July 29th. The medical instruments supplier reported $9.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.78 by $0.61. The firm had revenue of $978.39 million for the quarter, compared to analysts’ expectations of $951.81 million. Mettler-Toledo International had a net margin of 21.23% and a return on equity of 799.34%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $8.10 earnings per share. As a group, research analysts expect that Mettler-Toledo International Inc. will post 38.96 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Wah-Hui Chu sold 300 shares of the stock in a transaction on Friday, May 13th. The shares were sold at an average price of $1,268.00, for a total transaction of $380,400.00. Following the sale, the director now directly owns 3,075 shares of the company’s stock, valued at $3,899,100. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Mettler-Toledo International news, Director Olivier A. Filliol sold 12,500 shares of the stock in a transaction on Monday, May 16th. The shares were sold at an average price of $1,237.68, for a total transaction of $15,471,000.00. Following the sale, the director now directly owns 21,183 shares of the company’s stock, valued at $26,217,775.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Wah-Hui Chu sold 300 shares of the company’s stock in a transaction dated Friday, May 13th. The stock was sold at an average price of $1,268.00, for a total transaction of $380,400.00. Following the transaction, the director now owns 3,075 shares of the company’s stock, valued at approximately $3,899,100. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,871 shares of company stock valued at $62,238,873. Company insiders own 2.80% of the company’s stock.

About Mettler-Toledo International

(Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDGet Rating).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.